2014
DOI: 10.1016/j.lpm.2014.06.012
|View full text |Cite
|
Sign up to set email alerts
|

Prise en charge des onychomycoses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 14 publications
0
2
0
1
Order By: Relevance
“…Effective local antifungal agents include azole derivatives, ciclopiroxolamine, and possibly topical terbinafine. In addition, the most widely used systemic antifungal agents are fluconazole (150-300 mg/d one day a week) and itraconazole (400 mg/d one week a month) [24,26]. Treatment of esophageal candidiasis is immediately systemic.…”
Section: Discussionmentioning
confidence: 99%
“…Effective local antifungal agents include azole derivatives, ciclopiroxolamine, and possibly topical terbinafine. In addition, the most widely used systemic antifungal agents are fluconazole (150-300 mg/d one day a week) and itraconazole (400 mg/d one week a month) [24,26]. Treatment of esophageal candidiasis is immediately systemic.…”
Section: Discussionmentioning
confidence: 99%
“…Also, the nail plate prevents their desiccation, thus preserving a high percentage of moisture ( 5 ). Just like the biofilm site should be eliminated in cases of biofilm infections, many authors believe that OM can be cured only by avulsion (mechanical, chemical or surgical) of the nail ( 4 , 9 , 23 ), together with combined systemic and topical therapies. Since therapy is usually painstaking and lengthy (from three months with a systemic antimycotic to 18 months with topical therapy) ( 1 , 3 , 4 , 6 , 11 ), particular attention should be paid to the factors which are important for reaching an accurate diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…Leur traitement est long, les enjeux économiques qui en résultent sont importants, pourtant on constate souvent une stratégie thérapeu-tique peu adaptée, qui entraîne des traitements inutilement prolongés. Il faut ainsi savoir identifier les cinq formes d'onychomycoses à haut risque de résistance au traitement [5]. De nombreuses maladies cutanées, des maladies inflammatoires comme le psoriasis [6], mais aussi la pelade, le lichen plan, des maladies génétiques.…”
Section: Show Me Your Nails!unclassified